Skip Navigation
National Institute of Environmental Health SciencesNational Institutes of Health
Increase text size Decrease text size Print this page

Arsenic and Type 2 Diabetes

Ana Navas-Acien, M.D., Ph.D. and Ellen K. Silbergeld, Ph.D.
Johns Hopikins Bloomberg School of Public Health
NIEHS Grant P30ES003819

New research findings from the National Health and Nutrition Examination Survey suggest that exposure to levels of arsenic commonly found in drinking water may be a risk factor for type 2 diabetes. The findings suggest that millions of Americans may be at increased risk for type 2 diabetes based on the level of arsenic in their drinking water.

Data on the nearly 800 participants in the study for which urinary arsenic concentrations were available, indicated that urine levels of arsenic were significantly associated with the prevalence of type 2 diabetes. After splitting the subjects into 5 groups based on the level of arsenic in their urine, the researchers determined that those in the highest category were more than three and one-half times more likely to have diabetes. The strength of arsenic as a risk factor for diabetes is similar to other factors such as obesity.

Inorganic arsenic in drinking water at concentrations higher than 100 parts per million has been linked to type 2 diabetes in studies that took place in Taiwan, Mexico, and Bangladesh where drinking water is commonly contaminated with high levels of arsenic. The US drinking water standard is currently 10 parts per million, but most people on private wells have not had their water tested and aren’t required to. The researchers estimate that about 13 million Americans live in areas where public water systems exceed the EPA standard for arsenic and this number does not included private wells and water systems.

Animal studies have shown that arsenic affects the production of glucose, insulin secretion and can cause insulin resistance. The current findings reinforce the need to evaluate the role of arsenic in diabetes development in prospective epidemiologic studies conducted in populations exposed to a wide range of arsenic levels.

Citation: Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA. 2008 Aug 20;300(7):814-22.

USA.gov Department of Health & Human Services National Institutes of Health
This page URL: http://www.niehs.nih.gov/research/supported/sep/2008/arsenic.cfm
NIEHS website: http://www.niehs.nih.gov/
Email the Web Manager at webmanager@niehs.nih.gov
Last Reviewed: November 25, 2008